gsl1956
Member
I am a 60-year-old man, 6'2". In April 2016, TTE revealed 4.3cm dilation of ascending aorta. February of this year, MRA showed aneurysm increased to 4.5cm in 10 months. Family history of aortic aneurysm (mother-abdominal/deceased, grandfather-thoracic rupture with sudden death). Referred in May for FTAAD genetic testing. Test results identified a rare COL3A1 mutation as a "variation of unknown significance." The uncertainty of the VUS finding troubles me, given COL3A1 association with vascular Ehlers-Danlos Syndrome and that I share a few traits seen in EDS - historically easy bruising and free bleeding (e.g nosebleeds) and slow wound healing.
Given the VUS and familial history, how does an aortic surgeon take these factors into consideration for medical management/surveillance and elective surgical repair? Do surgeons intervene earlier due to the uncertainty around the variant associated with connective tissues disorder and early aortic rupture/dissection?
Given the VUS and familial history, how does an aortic surgeon take these factors into consideration for medical management/surveillance and elective surgical repair? Do surgeons intervene earlier due to the uncertainty around the variant associated with connective tissues disorder and early aortic rupture/dissection?